Lung cancer varies widely from patient to patient, and that diversity makes it hard to find effective treatments. Researchers at the Berlin Institute of Health at Charité (BIH) have developed a method ...

Affinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company advancing cancer diagnostics including CyPath® Lung, the Company’s commercially available test for early-stage lung cancer, ...

Sayaka Blickenderfer is a medical and science editor and writer with more than 10 years of experience. She edits and prepares scientific manuscripts and grant proposals for submission. Jane Kim, MD, ...

The American Lung Association is announcing a new initiative to help people living with chronic obstructive pulmonary disease (COPD) better manage symptoms and improve quality of life. More than 16 ...

Quitting smoking is one of the most important steps you can take for your health, but it's also one of the hardest. According to the Centers for Disease Control and Prevention (CDC), most adults who ...

Lung cancer remains the leading cause of cancer deaths in the United States and older adults are at higher risk. But only ...

It’s been a year since Australia launched its National Lung Cancer Screening Program. Since July 2025, about 100,000 ...

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.

Scientists have identified a blood-based protein signature that can predict lung cancer risk more than five years before diagnosis. Powered by AI and validated across global datasets, the breakthrough ...